Evaluating the Effectiveness of Implementation Intentions to Strengthen Approach-avoidance Training
Condition(s) studied
Investigational drug(s) / intervention(s)
Approach Bias Modification with Implementation Intentions: Participants in each experimental condition will perform different variants of the Approach-Avoidance Task (i.e., a task that is widely used in the litterature to assess and modify the approach bias toward alcohol - the relative ease to approach alcohol rather than to avoid it). Participants in the classical Approach Bias Modification conditions will perform a version of this task which will train them to (almost-)systematically emit an avoidance response toward alcohol ; Participants in the Approach Bias Modification with Implementation Intentions condition will perform the same version of the task but will additionnaly have to complete a planning intervention (i.e., implementation intentions) to help them avoiding alcohol; Participants in the Sham-training condition will perform a version of this task which require them to approach alcohol as often as they have to avoid it (i.e., no real training).
Study summary
Approach Bias Modifcation corresponds to computerized interventions designed to change a cognitive bias (i.e., the approach bias) that may contribute to the maintenance of Alcohol Use Disorder. This study aims to compare the effectiveness of a classical Approach Bias Modification program, an Approach Bias Modification program integrating a planning strategy (i.e., implementation intentions) and a Sham-training to decrease the approach bias (from pre to post-test), and Alcohol Use Disorder symptomatology (from baseline to follow-up). 112 patients will be recruited for this study.
Eligibility
Primary outcome measure(s)
- Approach-Avoidance Task (AAT) — 2 weeks
The approach bias toward alcohol
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Clinique la Mitterie | Lille | France | Recruiting |
More Clinique de la Mitterie trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06211959 on ClinicalTrials.gov ↗ ← All trials in France